Composition for ameliorating loss of hair and graying of hair, and use thereof

Patent metadata

Field	Value
Publication number	US-11298372-B2
Application number	US-202016885930-A
Country	US
Kind code	B2
Filing date	May 28, 2020
Priority date	Jan 12, 2016
Publication date	Apr 12, 2022
Grant date	Apr 12, 2022

Abstract

The present invention provides novel compositions for suppressing or improving hair loss, and compositions for suppressing or improving graying. More specifically, it provides agents that stabilize type XVII collagen expression, preferably agents that suppress the degradation of type XVII collagen by ELANE inhibitors and such, and compositions comprising a DNA repair-promoting agent or a DNA damage-suppressing agent as an active ingredient. Advantageous suppressive effects of hair loss and graying can be obtained when a composition comprising as an active ingredient a suppressive agent of type XVII collagen degradation such as an ELANE inhibitor is administered to a mammal. For the ELANE inhibitors, suppressive agents of type XVII collagen degradation and DNA repair-promoting agents, low-molecular compounds, polypeptides, proteins, antibodies, or nucleic acid medicine such as antisense oligos or siRNAs may be used. A method of screening for effective substances for suppression of hair loss and graying is also provided.

First claim

The invention claimed is:

1. A method for suppressing or improving hair graying in a mammal, comprising administering to the mammal a stabilizing agent of type XVII collagen expression, wherein the stabilizing agent of type XVII collagen expression is selected from the group consisting of an MMP inhibitor, an NADPH oxidase inhibitor, an oxidation inhibitor, and an ADAM inhibitor.

2. The method according to claim 1 , wherein the MMP inhibitor is selected from the group consisting of Marimastat, Batimastat, PD166793, Ro32-3555, WAY170523, UK370106, TIMP1, TIMP2, TIMP3, and TIMP4.

3. The method according to claim 1 , wherein the NADPH oxidase inhibitor is selected from the group consisting of apocynin, AEBSF, GK-136901, ML171, VAS2870, and VAS3947.

4. The method according to claim 1 , wherein the oxidation inhibitor is selected from the group consisting of ascorbic acid, edaravone, α-tocopherol, glutathione, catechin, and resveratrol.

5. The method according to claim 1 , wherein the ADAM inhibitor is selected from the group consisting of TAPI-2, Secophenol, GI254023X, Erythrolosamine, TIMP1, TIMP2, TIMP3, and TIMP4.

6. A method for suppressing or improving hair graying in a human subject, comprising administering apocynin to the human subject.

Assignees

• Univ Nat Corp Tokyo Medical & Dental

Inventors

• Nishimura Emi
• Matsumura Hiroyuki

Classifications

• A61K36/577

  Malvaceae (Mallow family) · CPC title

• A61K36/742

  Coffea, e.g. coffee · CPC title

• A61K36/74

  Rubiaceae (Madder family) · CPC title

• A61K36/185

  Magnoliopsida (dicotyledons) · CPC title

• A61K31/05

  Phenols {(cannabinoids A61K31/658)} · CPC title